Clinical characteristics, haemodynamics and treatment of pulmonary hypertension in sarcoidosis in a single centre, and meta-analysis of the published data

American Journal of Cardiology

Volumn 111, Issue 2, 2013, Pages 278-285

  Dobarro, David ^a   Schreiber, Benjamin Emmanuel ^a   Handler, Clive ^a   Beynon, Huw ^a   Denton, Christopher P ^a   Coghlan, John Gerard ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMBRISENTAN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BOSENTAN; ILOPROST; PROSTACYCLIN; SILDENAFIL; TREPROSTINIL;

6 MINUTE WALK TEST; ADULT; AGED; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART CATHETERIZATION; HEART FUNCTION TEST; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG FIBROSIS; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MALE; MEDICAL RECORD REVIEW; MEDLINE; META ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; WORLD HEALTH ORGANIZATION;

ANTIHYPERTENSIVE AGENTS; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; PROPORTIONAL HAZARDS MODELS; SARCOIDOSIS, PULMONARY; SURVIVAL RATE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84872037973     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.09.031     Document Type: Article

References (26)

1. A.F. Shorr, D.L. Helman, D.B. Davies, and S.D. Nathan Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics Eur Respir J 25 2005 783 788
2. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, C.P. Denton, C.G. Elliott, S.P. Gaine, M.T. Gladwin, Z.C. Jing, M.J. Krowka, D. Langleben, N. Nakanishi, and R. Souza Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 2009 S43 S54
3. H. Nunes, M. Humbert, F. Capron, M. Brauner, O. Sitbon, J.P. Battesti, G. Simonneau, and D. Valeyre Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis Thorax 61 2006 68 74
4. M.A. Judson, K.B. Highland, S. Kwon, J.F. Donohue, R. Aris, N. Craft, S. Burt, and H.J. Ford Ambrisentan for sarcoidosis associated pulmonary hypertension Sarcoidosis Vasc Diffuse Lung Dis 28 2011 139 145
5. N. Milman, C.M. Burton, M. Iversen, R. Videbaek, C.V. Jensen, and J. Carlsen Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil? J Heart Lung Transplant 27 2008 329 334
6. K.A. Fisher, D.M. Serlin, K.C. Wilson, R.E. Walter, J.S. Berman, and H.W. Farber Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenoltreatment Chest 130 2006 1481 1488
7. C.F. Barnett, E.J. Bonura, S.D. Nathan, S. Ahmad, O.A. Shlobin, K. Osei, A.L. Zaiman, P.M. Hassoun, D.R. Moller, S.D. Barnett, and R.E. Girgis Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience Chest 135 2009 1455 1461
8. J.P.T. Higgins, J.J. Deeks, and D.G. Altman Special topics in statistics J.P.T. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions 2008 John Wiley New York, New York 16.1 16.39
9. B.C. Wallace, C.H. Schmid, J. Lau, and T.A. Trikalinos Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data BMC Med Res Methodol 9 2009 80
10. R.P. Baughman, M.A. Judson, E.E. Lower, K. Highland, S. Kwon, N. Craft, and P.J. Engel Inhaled iloprost for sarcoidosis associated pulmonary hypertension Sarcoidosis Vasc Diffuse Lung Dis 26 2009 110 120
11. R.P. Baughman, P.J. Engel, L. Taylor, and E.E. Lower Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation Chest 138 2010 1078 1085
12. J.M. Bourbonnais, and L. Samavati Clinical predictors of pulmonary hypertension in sarcoidosis Eur Respir J 32 2008 296 302
13. D.A. Culver, and R.A. Krasuski Right-sided heart catheterization: de rigueur in sarcoidosis? Chest 138 2010 1030 1032
14. N. Galiè, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, J.A. Barbera, M. Beghetti, P. Corris, S. Gaine, J.S. Gibbs, M.A. Gomez-Sanchez, G. Jondeau, W. Klepetko, C. Opitz, A. Peacock, L. Rubin, M. Zellweger, and G. Simonneau Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J 30 2009 2493 2537
15. S.M. Arcasoy, J.D. Christie, A. Pochettino, B.R. Rosengard, N.P. Blumenthal, J.E. Bavaria, and R.M. Kotloff Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation Chest 120 2001 873 880
16. D.A. Lynch, J.D. Godwin, S. Safrin, K.M. Starko, P. Hormel, K.K. Brown, G. Raghu, T.E. King Jr., W.Z. Bradford, D.A. Schwartz, and W. Richard Webb High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis Am J Respir Crit Care Med 172 2005 488 493
17. M.C. van de Veerdonk, T. Kind, J.T. Marcus, G.J. Mauritz, M.W. Heymans, H.J. Bogaard, A. Boonstra, K.M. Marques, N. Westerhof, and A. Vonk-Noordegraaf Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy J Am Coll Cardiol 58 2011 2511 2519
18. E. Cantu III, and D. Davis Jr. Lung transplantation: timing, perioperative considerations and postoperative outcome Adv Pulm Hypertens 3 2004 9 18
19. H.J. Reesink, J.T. Marcus, Tulevski II, S. Jamieson, J.J. Kloek, A. VonkNoordegraaf, and P. Bresser Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle J Thorac Cardiovasc Surg 133 2007 58 64
20. N. Galiè, H.A. Ghofrani, A. Torbicki, R.J. Barst, L.J. Rubin, D. Badesch, T. Fleming, T. Parpia, G. Burgess, A. Branzi, F. Grimminger, M. Kurzyna, G. Simonneau Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group Sildenafil citrate therapy for pulmonary arterial hypertension N Engl J Med 353 2005 2148 2157
21. O. Sitbon, D.B. Badesch, R.N. Channick, A. Frost, I.M. Robbins, G. Simonneau, V.F. Tapson, and L.J. Rubin Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study Chest 124 2003 247 254
22. L.J. Smith, J.B. Lawrence, and A. Katzenstein Vascular sarcoidosis: a rare cause of pulmonary hypertension Am J Med Sci 285 1983 38 44
23. L.J. Rubin, D.B. Badesch, R.J. Barst, N. Galie, C.M. Black, A. Keogh, T. Pulido, A. Frost, S. Roux, I. Leconte, M. Landzberg, and G. Simonneau Bosentan therapy for pulmonary arterial hypertension N Engl J Med 346 2002 896 903
24. J. Kjaergaard, C.L. Petersen, A. Kjaer, B.K. Schaadt, J.K. Oh, and C. Hassager Evaluation of right ventricular volume and function by 2D and 3D echocardiography compared to MRI Eur J Echocardiogr 7 2006 430 438
25. M.D. Puchalski, R.V. Williams, B. Askovich, L.L. Minich, C. Mart, and L.Y. Tani Assessment of right ventricular size and function: echo versus magnetic resonance imaging Congenit Heart Dis 2 2007 27 31
26. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med 161 2000 646 664